Valeo Pharma Inc VPHIF

Healthcare Biotechnology

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.

GREY:VPHIF - Post by User

Valeo Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by bmreedon Mar 06, 2022 12:30pm

293 Views

Post# 34488058

Webinar Recap w Radius Research and $VPH CEO Steve Saviuk

Webinar Recap: Valeo Pharma (VPH) w CEO Steve Saviuk - Commercializing Innovative Prescription Products in Canada - Pitch, Deep Dive and Q&A - https://www.youtube.com/watch?v=8hQ51RBuPUA